91 related articles for article (PubMed ID: 10323078)
1. [Heparin therapy: from the viewpoint of 1998].
Takalo L; Jakab L
Orv Hetil; 1999 Apr; 140(15):860-1. PubMed ID: 10323078
[No Abstract] [Full Text] [Related]
2. [Site of action of anticoagulant drugs].
Capel P
Rev Med Brux; 1985 Mar; 6(3):131-3. PubMed ID: 3992078
[No Abstract] [Full Text] [Related]
3. [The effect of heparin on the functioning of the hemostasis system in patients with insulin-dependent diabetes mellitus in severe forms of diabetic foot].
Garbaruchuk OI; Malyzhev VO
Ukr Biokhim Zh (1978); 1998; 70(5):111-6. PubMed ID: 10445270
[TBL] [Abstract][Full Text] [Related]
4. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.
Hettiarachchi RJ; Smorenburg SM; Ginsberg J; Levine M; Prins MH; Büller HR
Thromb Haemost; 1999 Aug; 82(2):947-52. PubMed ID: 10605808
[No Abstract] [Full Text] [Related]
5. Management of deep vein thrombosis in cancer patients.
Jahanzeb M
J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
[No Abstract] [Full Text] [Related]
6. Heparin and low molecular weight heparin in thrombosis and beyond.
Mousa SA
Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
[TBL] [Abstract][Full Text] [Related]
7. [New medical anticoagulants].
Choussat R; Montalescot G
Rev Mal Respir; 1999 Nov; 16(5 Pt 2):985-95. PubMed ID: 10907447
[TBL] [Abstract][Full Text] [Related]
8. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
Koster A; Fischer T; Gruendel M; Mappes A; Kuebler WM; Bauer M; Kuppe H
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):171-5. PubMed ID: 12698397
[TBL] [Abstract][Full Text] [Related]
9. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
Greaves M;
Thromb Haemost; 2002 Jan; 87(1):163-4. PubMed ID: 11848446
[No Abstract] [Full Text] [Related]
10. New antithrombin-based anticoagulants.
Desai UR
Med Res Rev; 2004 Mar; 24(2):151-81. PubMed ID: 14705167
[TBL] [Abstract][Full Text] [Related]
11. Heparin: the cheap alternative for immunomodulation in sepsis?
Robertson MS
Crit Care Resusc; 2006 Sep; 8(3):235-8. PubMed ID: 16930112
[TBL] [Abstract][Full Text] [Related]
12. Why warfarin and heparin need to overlap when treating acute venous thromboembolism.
Wittkowsky AK
Dis Mon; 2005; 51(2-3):112-5. PubMed ID: 15900262
[No Abstract] [Full Text] [Related]
13. Heparin treatment in pregnancy loss: Potential therapeutic benefits beyond anticoagulation.
Girardi G
J Reprod Immunol; 2005 Jun; 66(1):45-51. PubMed ID: 15949561
[TBL] [Abstract][Full Text] [Related]
14. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
Delsart D; Chambefort V; Decousus H
Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
[No Abstract] [Full Text] [Related]
15. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulants in coronary artery disease.
Lee LV
Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
[TBL] [Abstract][Full Text] [Related]
17. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
Haas S
Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
[TBL] [Abstract][Full Text] [Related]
18. Are heparins anti-neoplastic agents?
Douketis JD; Lloyd NS
Pol Arch Med Wewn; 2007; 117(11-12):491-3. PubMed ID: 18363247
[No Abstract] [Full Text] [Related]
19. Heparin in tumor progression and metastatic dissemination.
Falanga A; Marchetti M
Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796
[TBL] [Abstract][Full Text] [Related]
20. [Multiple cholesterol emboli syndrome: beneficial effects of early heparin therapy. A case report].
Lekeufack JB; Delrée P; Goergen M; Bouazza F; Salmon K; Raynal P; Azagra JS; Sellitti E; Dehon P
Ann Cardiol Angeiol (Paris); 1999 Oct; 48(8):575-8. PubMed ID: 12555463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
